Relations between medical history, clinical findings and plasma N-terminal proatrial natriuretic peptide in patients in primary health care

European Journal of Heart Failure

Volumn 3, Issue 3, 2001, Pages 307-313

  Smith, Jørgen A ^a,d   Bruusgaard, Dag ^b   Bodd, Egil ^c   Hall, Christian ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c National Hospital ^*  (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

General practice; Heart failure; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; GENERAL PRACTICE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MEDICAL HISTORY TAKING; NORWAY; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROTEIN PRECURSORS; REGRESSION ANALYSIS;

EID: 0034821443     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00124-6     Document Type: Article

References (29)

1. Validity of clinical diagnosis of heart failure in primary health care
2. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
3. Echocardiography in chronic heart failure in the community
4. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
5. A new natriuretic peptide in porcine brain
6. The propeptide Asn 1-Tyr 126 is the storage form of rat atrial natriuretic factor
7. Gamma-Atrial natriuretic polypeptide (gammaANP)-derived peptides in human plasma: Cosecretion of N-terminal gammaANP fragment and alfaANP
8. NH2- terminal fragment of rat proatrial natriuretic factor in the circulation: Identification, radioimmunoassay and half-life
9. Identification and plasma concentration of the N terminal fragment of proatrial natriuretic factor in man
10. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: An important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine
11. Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy subjects
12. Plasma Nterminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
13. N-terminal proatrial natriuretic factor- an important and independent predictor of long term prognosis after myocardial infarction
14. Plasma N-terminal atrial natriuretic factor: A predictor of survival in patients with congestive heart failure
15. Neuroendocrine activity in untreated heart failure
16. The epidemiology of heart failure
17. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left ventricular dysfunction
18. Atriopeptin turnover: Quantitative relationship between in vivo changes in plasma levels and atrial content
19. Atrial peptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population
20. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: Evidence from a population-based study
21. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: A longitudinal study
22. Effects of angiotensin II receptor blockage on N-terminal proatrial natriuretic factor plasma levels in chronic heart failure
23. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (The randomized aldactone evaluation)
24. Hemodynamics of idiopathic paroxysmal atrial fibrillation
25. Biochemical detection of left-ventricular systolic dysfunction
26. Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventric ular hypertrophy in the general population. Tromso study
27. Guidelines for the diagnosis of heart failure. Task force of the ESC on heart failure
28. Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?
29. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction